Peraso Registers 31.75M Shares for $25M Equity Line — Potential 68% Dilution
PRSO is trading near its 52-week low of $0.734 (5.1% above the low) on light trading volume (0.2× avg).
Summary
Peraso's $25M equity line prospectus is effective, registering 31.75M shares for resale. If fully drawn, dilution hits ~68% for a company already under going-concern pressure.
Key Events · Financing and Capital Events · PRSO
-
Equity Line Registration Effective
The registration statement for up to 31.75 million shares under the $25 million committed equity facility with Roth Principal Investments has been declared effective.
-
Massive Potential Dilution
If all 31.75M shares are issued, they would represent approximately 67.9% of the current 15.04M outstanding shares, severely diluting existing holders.
-
Discounted Sales Create Overhang
Shares will be sold to Roth at a 3% discount for market, open, or intraday purchases, or a 5% discount for pre- or post-market transactions, with the investor free to resell immediately at market.
-
Exchange Cap Limits Immediate Sales
Without stockholder approval, Nasdaq rules cap issuance at 3,004,114 shares (19.99% of outstanding), unless the average sale price exceeds $0.9853.
Analysis · PRSO · Manufacturing
With the registration statement now effective, Peraso can tap its $25 million committed equity facility by selling shares to Roth Principal Investments at a discount. The prospectus covers 31.75 million shares—if fully issued, existing holders face roughly 68% dilution. That lifeline arrives as the company confronts a going-concern warning and dwindling cash, making the facility essential but costly. Yesterday's close was $0.755, and sales will occur at a 3–5% discount to market, creating immediate overhang. Without stockholder approval, only 3 million shares can be sold, yet the full registration signals intent to draw the entire $25 million if necessary.
At the time of this filing, PRSO was trading at $0.77 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $0.73 to $2.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.